Identification and biopsy of the sentinel lymph node in breast cancer

European Journal of Surgical Oncology

Volumn 24, Issue 5, 1998, Pages 427-430

  Kapteijn, B A E ^a   Nieweg, O E ^a   Petersen, J L ^a   Rutgers, E J Th ^a   Hart, A A M ^a   Van Dongen, J A ^a   Kroon, B B R ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

Breast carcinoma; Lymphadenectomy; Sentinel node

Indexed keywords

DISULFINE BLUE;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CARCINOMA; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; HUMAN; LYMPH NODE; LYMPH NODE BIOPSY; LYMPH NODE DISSECTION; MASTECTOMY; PRIORITY JOURNAL; PROGNOSIS; SEGMENTAL MASTECTOMY; STAINING; TUMOR;

EID: 0031724448     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0748-7983(98)92372-1     Document Type: Article

References (26)

1. Fisher B, Redmond C, Fisher ER, Bauer M, Wolmark N, Wickerham DL, Deutsch M, Montague E, Margolese R, Foster R. Ten year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. N Engl J Med 1985; 312: 674-81.
2. Harris JR, Osteen RT. Patients with early breast cancer benefit from effective axillary treatment. Breast Cancer Res Treat 1985; 5: 17-21.
3. Cascinelli N, Greco M, Bufalino R, Clemente C, Galluzzo D, delle Donne V, de Lellis R, Sacchini V, Veronesi U. Prognosis of breast cancer with axillary node metastases after surgical treatment. Eur J Cancer Clin Oncol 1987; 23: 795-9.
4. Steele RJC, Forrest APM, Gibson T, Stewart HJ, Chetty U. The efficacy of lower axillary sampling in obtaining lymph node status in breast cancer: a controlled randomized trial. Br J Surg 1985; 72: 368-9.
5. Siegel BM, Mayzel KA, Love SM. Level I and II axillary dissection in the treatment of early-stage breast cancer. An analysis of 259 consecutive patients. Arch Surg 1990; 125: 1144-7.
6. Kissin MW, Querci della Rovere G, Easton D, Westbury G. Risk of lymphoedema following the treatment of breast cancer. Br J Surg 1986; 73: 580-4.
7. Sacre RA. Clinical evaluation of axillary lymph nodes compared to surgical and pathological findings. Eur J Surg Oncol 1986; 12: 169-73.
8. Fisher B, Wolmark N, Bauer M, Redmond C, Gebhardt M. The accuracy of clinical nodal staging is limited. Limited axillary dissection as a determinate of histologic nodal status in carcinoma of the breast is enough. Survival not better with complete axillary node dissection. Surg Gynecol Obstet 1981; 152: 765-72.
9. Musumeci R, Monica G, Orefice S, Paolucci R, Petrillo R, Uslenghi C. Lymphographic evaluation of 250 patients with malignant melanoma. Cancer 1976; 38: 1568-73.
10. Isaacs RJ, Ford JM, Allan SG, Forgeson GV, Gallagher S. Role of computed tomography in the staging of primary breast cancer. Br J Surg 1993; 80: 1137.
11. Tate JJT, Lewis V, Archer T, Guyer PG, Royle GT, Taylor I. Ultrasound detection of axillary lymph node metastases in breast cancer. Eur J Surg Oncol 1989; 15: 139-41.
12. Maublant J, de Latour M, Mestas D, Clemenson A, Charrier S, Feillel V, Le Bouedec G, Kaufman P, Dauplat J, Veyre A. Technetium-99m-Sestamibi uptake in breast tumor and associated lymph nodes. J Nucl Med 1996; 37: 922-5.
13. Nieweg OE, Kim EE, Wong W-H, Broussard WF, Singletary SE, Hortobagyi GN, Tilbury RS. Positron emission tomography with fluorine-18-deoxyglucose in the detection and staging of breast cancer. Cancer 1993; 71: 3920-5.
14. Wahl RL, Cody RI, Hutchins GD, Mudgett EE. Primary and metastatic breast carcinoma: initial clinical evaluation with PET with the radiolabeled glucose analogue 2-[F-18]-fluoro-2-deoxy-D-glucose. Radiology 1991; 179: 765-70.
15. Morton DL, Wen D-R, Wong JH, Economou JS, Cagle LA, Storm FK, Foshag LJ, Cochran AJ. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992; 127: 392-9.
16. Albertini JJ, Cruse CW, Rapaport D, et al. Intraoperative radiolymphoscintigraphy improves sentinel lymph node identification for patients with melanoma. Ann Surg 1996; 223: 217-24.
17. Kapteijn BAE, Nieweg OE, Liem IH, Muller SH, Hoefnagel CA, Valdés Olmos RA, Rutgers EJTh, Balm AJM, Kroon BBR. Localizing the sentinel node in melanoma: the probe versus patent blue dye. Ann Surg Oncol 1997; 4: 156-60.
18. Thompson JF, McCarthy WH, Bosch CMJ, et al. Sentinel lymph node status as an indicator of the presence of metastatic melanoma in regional lymph nodes. Melanoma Res 1995; 5: 255-60.
19. Krag DN, Meijer SJ, Weaver DL, Loggie BW, Harlow SP, Tanabe KK, Laughlin EH, Alex JC. Minimal-access surgery for staging of malignant melanoma. Arch Surg 1995; 130: 654-8.
20. Bland KI, Souba WW, Copeland EM. Surgery for benign and malignant disease of the breast: indications and techniques. In: Bland KI, Karakousis CP, Copeland RM (eds) Atlas of Surgical Oncology. Philadelphia: W.B. Saunders, 1995; 181-229.
21. Giuliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994; 220: 391-401.
22. Uren RF, Howman-Giles RB, Thompson JF, Malouf D, Ramsey-Stewart G, Niesche FW, Renwick SB. Mammary lymphoscintigraphy in breast cancer. J Nucl Med 1995; 36: 1775-80.
23. Krag DN, Weaver DL, Alex JC, Fairbank JT. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol 1993; 2: 335-40.
24. Veronesi U, Paganelli G, Galimberti V, et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph nodes. Lancet 1997; 349: 1864-7.
25. Giuliano AE, Dale PS, Turner RR, Morton DL, Evans SW, Krasne DL. Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann Surg 1995; 222: 394-401.
26. Wang X, Heller R, VanVoorhis N, et al. Detection of submicroscopic lymph node metastases with polymerase chain reaction in patients with malignant melanoma. Ann Surg 1994; 22: 768-74.